Guidelines for Corticosteroid use in Treatment of DMD
The guideline development subcommittee of the American Academy of Neurology has provided an update to the 2005 treatment guidelines for use of corticosteroids (CS) in Duchenne muscular dystrophy (DMD).
Main Author: | Vamshi K. Rao |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Neurology Briefs Publishers
2016-07-01
|
Series: | Pediatric Neurology Briefs |
Subjects: | |
Online Access: | https://www.pediatricneurologybriefs.com/articles/1693 |
Similar Items
-
Outcome of Long-Term Corticosteroid Treatment in Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (2007-06-01) -
Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry
by: Leslie Cowen, et al.
Published: (2019-05-01) -
Interpretation of "Chinese guidelines for diagnosis and treatment of pseudohypertrophy muscular dystrophy"
by: Cheng ZHANG
Published: (2018-07-01) -
Analysis of DMD translocations
by: Cockburn, David James
Published: (1991) -
Clinical study of DMD gene point mutation causing Becker muscular dystrophy
by: Ji-qing CAO, et al.
Published: (2015-06-01)